Published in Nucleic Acids Res on August 11, 1993
Maintaining the integrity of human immunodeficiency virus sequence databases. J Virol (1996) 2.68
Reliability of methods for hepatitis B virus DNA detection. J Clin Microbiol (1995) 2.16
False-positive results and contamination in nucleic acid amplification assays: suggestions for a prevent and destroy strategy. Eur J Clin Microbiol Infect Dis (2004) 1.57
Transcript quantitation in total yeast cellular RNA using kinetic PCR. Nucleic Acids Res (2000) 1.53
Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc Natl Acad Sci U S A (1996) 1.30
Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR. J Clin Microbiol (2001) 1.21
Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J Clin Microbiol (1995) 1.20
Control of carry-over contamination for PCR-based DNA methylation quantification using bisulfite treated DNA. Nucleic Acids Res (2006) 1.17
Detection of human respiratory syncytial virus in respiratory samples by LightCycler reverse transcriptase PCR. J Clin Microbiol (2002) 1.15
Detecting Newcastle disease virus in combination of RT-PCR with red blood cell absorption. Virol J (2011) 0.88
Quantitative assessment of the effect of uracil-DNA glycosylase on amplicon DNA degradation and RNA amplification in reverse transcription-PCR. Virol J (2005) 0.81
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Avoiding false positives with PCR. Nature (1989) 30.66
Utilizing uracil DNA glycosylase to control carryover contamination in PCR: characterization of residual UDG activity following thermal cycling. Biotechniques (1992) 1.48
What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors? Lancet (1989) 2.63
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Inhibition by desferrioxamine of in-vitro replication of HIV-1. Lancet (1991) 2.05
Comparative virulence and immunogenicity of the Towne strain and a nonattenuated strain of cytomegalovirus. Ann Intern Med (1984) 2.01
In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection. J Infect Dis (2008) 1.67
Measures to prevent TRALI. Vox Sang (2007) 1.58
Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group. N Engl J Med (1990) 1.55
Silent infections with human immunodeficiency virus type 1 are highly unlikely in multitransfused seronegative hemophiliacs. Blood (1990) 1.49
Serological confirmation of human T-lymphotropic virus type I infection in healthy blood and plasma donors. Blood (1989) 1.47
Analysis of live, oral poliovirus vaccine monopools for human immunodeficiency virus type 1 and simian immunodeficiency virus. J Infect Dis (1996) 1.42
Antibodies to simian immunodeficiency virus in African green monkeys in Africa in 1957-62. Lancet (1986) 1.25
Efficacy of ceftriaxone in serious bacterial infections. Antimicrob Agents Chemother (1982) 1.23
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex. Proc Natl Acad Sci U S A (1990) 1.19
Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis (1985) 1.13
Poor sensitivity, specificity, and reproducibility of detection of HIV-1 DNA in serum by polymerase chain reaction. The Transfusion Safety Study Group. J Acquir Immune Defic Syndr (1992) 1.12
HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J Immunol (1996) 1.06
Inactivation and partition of human T-cell lymphotrophic virus, type III, during ethanol fractionation of plasma. Transfusion (1986) 1.03
Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J Immunol (1997) 1.02
HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol (1996) 1.01
Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis. J Immunol (1999) 0.99
HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J Immunol (1995) 0.98
Development of a multiplex PCR assay for the simultaneous detection and discrimination of HIV-1, HIV-2, HTLV-I and HTLV-II. Clin Diagn Virol (1996) 0.98
Serodiagnosis of infection with the AIDS virus and other human retroviruses. Annu Rev Microbiol (1989) 0.97
Testing for antibodies to human immunodeficiency virus type 2 in the United States. MMWR Recomm Rep (1992) 0.97
Kinetics of early HIV-1 gene expression in infected H9 cells assessed by PCR. Oncogene (1991) 0.95
Interferon-gamma inhibits HIV-induced invasiveness of monocytes. J Leukoc Biol (1995) 0.92
Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains. Proc Natl Acad Sci U S A (1995) 0.91
Co-amplification of specific sequences of HCV and HIV-1 genomes by using the polymerase chain reaction assay: a potential tool for the simultaneous detection of HCV and HIV-1. J Virol Methods (1991) 0.91
Inactivation of human T-cell lymphotropic virus, type III by heat, chemicals, and irradiation. Transfusion (1986) 0.91
Chemokine receptors and HIV-2. AIDS (1997) 0.89
Co-amplification of multiple regions of the HIV-1 genome by the polymerase chain reaction: potential use in multiple diagnosis. Oncogene (1989) 0.89
Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome. Ann N Y Acad Sci (1984) 0.88
Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents. AIDS Res Hum Retroviruses (1993) 0.88
Rubella virus replication: effect of interferons and actinomycin D. Virus Res (1988) 0.88
Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study. Transfusion (1999) 0.87
Rapid and sensitive detection of cell-associated HIV-1 in latently infected cell lines and in patient cells using sodium-n-butyrate induction and RT-PCR. J Med Virol (1997) 0.86
Nucleotide sequence and restriction fragment-length polymorphism analysis of human T-cell lymphotropic virus type II (HTLV-II) in southern Europe: evidence for the HTLV-IIa and HTLV-IIb subtypes. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.86
Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes. Pathobiology (1995) 0.86
Sensitivity and consistency of screening tests for antibodies to human immunodeficiency virus type 1. Transfusion (1991) 0.86
Deficient, HLA-restricted, cytomegalovirus-specific cytotoxic T cells and natural killer cells in patients with the acquired immunodeficiency syndrome. J Infect Dis (1985) 0.84
Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Association of antigenemia with symptomatic disease and T-helper cell depletion. Ann Intern Med (1987) 0.84
Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 0.84
9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone. AIDS Res Hum Retroviruses (1998) 0.84
Enhanced diagnostic efficiency of the polymerase chain reaction by co-amplification of multiple regions of HIV-1 and HIV-2. J Virol Methods (1994) 0.83
Evidence of HIV-2 infection in Equatorial Guinea (central Africa): partial genetic analysis of a B subtype virus. AIDS Res Hum Retroviruses (1997) 0.83
Phylogenetic analysis of HIV type 2 strains from Portugal. AIDS Res Hum Retroviruses (1998) 0.82
Mechanisms of T-cell functional deficiency in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 0.81
Interferon-gamma induces resistance in primary monocytes against human immunodeficiency virus type-1 infection. Biochem Biophys Res Commun (1994) 0.81
Fluoride content of popular carbonated beverages. J Prev Dent (1978) 0.80
Inhibition of HIV replication by immunoliposomal antisense oligonucleotide. Antiviral Res (1996) 0.80
Hemolysis and acute renal failure due to the administration of albumin diluted in sterile water. Transfusion (1999) 0.79
Genetic analysis of an HIV type 2 subtype B virus from a Spanish individual with AIDS. AIDS Res Hum Retroviruses (1997) 0.79
Sequence analysis of the V1/V2 and V3 domains in an HIV-seronegative AIDS patient. AIDS Res Hum Retroviruses (1995) 0.78
Enterobacter cloacae bloodstream infections traced to contaminated human albumin. Clin Infect Dis (2000) 0.77
Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses. Transfusion (2000) 0.77
Impaired antigen presentation to CD4+ T-cells by HIV-infected monocytes is related to down-modulation of CD4 expression on helper T-cells: possible involvement of HIV-induced cellular factors. FEBS Lett (1996) 0.77
Prevention of herpes simplex virus diseases in man. Clin Dermatol (1986) 0.77
The effects of the AIDS epidemic on the safety of the nation's blood supply. Public Health Rep (1988) 0.77
Viral infections and cell-mediated immunity in immunodeficient homosexual men with Kaposi's sarcoma treated with human lymphoblastoid interferon. J Infect Dis (1985) 0.76
Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening. Transfusion (1997) 0.76
Reactive follicular hyperplasia of intraparotid lymphoid tissue presenting as a recurrent parotid enlargement. Pediatr Pathol (1992) 0.76
V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infection. AIDS (1999) 0.76
An anti-p24 monoclonal antibody shows cross-reactivity with multiple HIV-1 proteins. J Immunol Methods (1990) 0.75
A trial of RSV immune globulin in infants and young children: the FDA's view. N Engl J Med (1994) 0.75
Layered wound closure. Dermatol Surg (1999) 0.75
Absence of infectious human immunodeficiency virus type 1 in "natural" eccrine sweat. J Infect Dis (1992) 0.75
Subspecialization. Arch Otolaryngol Head Neck Surg (1994) 0.75
Interagency Genome Amplification Testing Task Force: preliminary report. Transfusion (1998) 0.75
A rapid, sensitive, PCR-based method for detection of HIV-1 specific nucleic acid in the culture supernatant of infected cells. Ann N Y Acad Sci (1993) 0.75
A novel, sensitive radioimmunoprecipitation assay for the detection of antibodies to human immunodeficiency virus-type 2. J Virol Methods (1993) 0.75
Genetic analysis of human immunodeficiency virus type 2 strains from Spain. AIDS Res Hum Retroviruses (1998) 0.75
Detection of acquired B antigen by monoclonal anti-B blood grouping reagents. Transfusion (1997) 0.75
HIV-1 infects and alters immune function of a monocyte subset expressing low CD14 surface phenotype. Viral Immunol (2000) 0.75
Detection of herpesvirus type 8 (HHV-8) sequences in patients with Kaposi's sarcoma in Spain. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 0.75
Absence of evidence of retrovirus infection in intravenous drug users with idiopathic CD4+ lymphocytopenia. J Infect Dis (1994) 0.75
Detection of HIV-1 by RNA PCR in factor VIII concentrates. Vox Sang (1994) 0.75
Idiopathic CD4+ T lymphocytopenia: a review and current perspective. Transfus Med Rev (1994) 0.75
Studies on the antioxidant action of thyroxine and related compounds. J Med Chem (1967) 0.75
Interaction between Cu(II) and thyroxine-like compounds in mitochondrial swelling studies. Endocrinology (1967) 0.75